Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models
about
Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potent efficacy signals from s ...... lar carcinoma xenograft models
@en
Potent efficacy signals from systemically administered oncolytic herpes simplex virus
@nl
type
label
Potent efficacy signals from s ...... lar carcinoma xenograft models
@en
Potent efficacy signals from systemically administered oncolytic herpes simplex virus
@nl
prefLabel
Potent efficacy signals from s ...... lar carcinoma xenograft models
@en
Potent efficacy signals from systemically administered oncolytic herpes simplex virus
@nl
P2093
P2860
P356
P1476
Potent efficacy signals from s ...... lar carcinoma xenograft models
@en
P2093
Alex Graham
Joe Conner
Kirsty Learmonth
Lynne Braidwood
P2860
P304
P356
10.2147/JHC.S71019
P577
2014-10-16T00:00:00Z